Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology

Arrese, Marco

doi:10.1016/j.aohep.2020.05.002

Cited by 13 publications

(12 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Also, the response to the COVID‐19 pandemic has created new opportunities to strengthen hepatitis elimination efforts. For example, the strengthening of the telemedicine infrastructure, as well as expansion of diagnostic capacity can innovate hepatitis care, expanding access to hepatitis testing and treatment 7,8 . The varied use of mitigation strategies across regions reveals the value of sharing lessons learned to translate these innovative strategies into simpler models of routine hepatitis care.…”

Section: Discussionmentioning

confidence: 99%

Impact of COVID‐19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers

Laury

Hiebert

Ward

2021

Clinical Liver Disease

View full text Add to dashboard Cite

The achievement of goals for elimination of hepatitis B virus (HBV) and hepatitis C virus (HCV) requires broad access to HBV and HCV testing and treatment services. 1 In response to the coronavirus disease 2019 (COVID-19) pandemic, American Association for the Study of Liver Diseases (AASLD) and other liver associations recommended changes in hepatitis clinical care to mitigate transmission risks for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. 2 In 2020, the Coalition for Global Hepatitis Elimination (CGHE) surveyed clinicians and program managers to assess the mitigation strategies deployed to reduce transmission and the changes in access to hepatitis testing and treatment services. MeTHODs A 53-question online survey was developed in SmartSheet by CGHE and partners,* translated into French and Spanish, and distributed via websites and e-mail. Responses were received between August 12, 2020, and December 16, 2020. Respondents were not required to answer all questions.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of COVID‐19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers

Laury

Hiebert

Ward

2021

Clinical Liver Disease

View full text Add to dashboard Cite

show abstract

“…It is accepted that telemedicine improves the efficiency of healthcare delivery at reasonable cost opportunities for patients with chronic liver diseases by increasing their access to tertiary care. However, telemedicine may not be available in many countries, and strategies including phone calls ad/or virtual consultation for remote care must be used [ 12 ]. By taking into account that the severity of most COVID-19-associated liver injuries is considered mild, suggesting that liver failure is uncommon among critical COVID-19 patients and the fact that liver dysfunction has been mainly described in patients with severe disease upon presentation.…”

mentioning

confidence: 99%

COVID-19 and the liver: What do we know after six months of the pandemic?

Fierro

2020

Annals of Hepatology

View full text Add to dashboard Cite

Despite liver injury in patients infected with severe acute respiratory syndrome (SARS) coronavirus (CoV)-2 (SARS-CoV-2) is associated with prolonged hospitalization, and liver dysfunction is mainly described in patients with severe viral disease. How liver abnormalities may affect virus infection is still unknown. Improved understanding of host genetics, lifestyle, underlying comorbidities and adequate follow-up of patients with liver damage are critical in the new scenario of the pandemic virus.

show abstract

“…The main medical resources are concentrated in cities, even in those regions of the Russian Federation, where the majority live in rural areas [20,21]. Some regions still have difficulties in transport accessibility provision from healthcare organizations; in the use of communication facilities, almost all constituent entities of the Russian Federation are faced with the problem of a shortage of doctors and other medical workers in rural and remote areas [22].…”

Section: Introductionmentioning

confidence: 99%

Untitled

et al. 2021

View full text Add to dashboard Cite

A complex of six advanced training programs for the management of a portable telemedicine complex was developed on the basis of Federal State Budgetary Educational Institution of Higher Education "North-Western State Medical University named after I.I. Mechnikov", the Ministry of Health of the Russian Federation. A pilot training program "Operator of a portable telemedicine complex" was implemented for persons with a full-time graduate degree. 17 trainees took part in the program. According to the results of the program, all the trainees had passed certification testing successfully and demonstrated sufficient development of the digital competence of portable telemedicine complex operators to optimizing the provision of medical care. The results of the program allowed to identify positive aspects of its implementation, namely training in a comfortable and familiar environment by 85.7%; the opportunity to combine work and studies by 57.1%; and the opportunity for repetitive self-assessment by 28.6%. The article presents the results of the study under the additional agreement dated September 24, 2020 No. 075-15-2019-1346/1 to the agreement dated June 13, 2019 No. 075-15-2019-1346 with the Ministry of Science and Higher Education of the Russian Federation as a part of implementing the federal target program "Research and development in priority areas of development of the scientific and technological complex of Russia for 2014-2020", event 1.2, stage 01 Code: 2018-14-000-0001) on the topic "Development of a portable telemedicine complex for optimizing the provision of medical care"(UIP of the project: No. УИП RFMEFI60418X0201).

show abstract

Telemedicine, COVID-19 and liver diseases: Revamping remote care initiatives in hepatology

Cited by 13 publications

References 16 publications

Impact of COVID‐19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers

Impact of COVID‐19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers

COVID-19 and the liver: What do we know after six months of the pandemic?

Untitled

Contact Info

Product

Resources

About